NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that its RNS System and NeuroPace AI platform will be ...
-- 18-month data show a 77% median reduction in generalized tonic-clonic (GTC) seizures, supporting forthcoming PMA supplement submission -- -- Remains on track to submit NAUTILUS PMA Supplement to ...
In the latest quarter, 4 analysts provided ratings for NeuroPace (NASDAQ:NPCE), showcasing a mix of bullish and bearish perspectives. Summarizing their recent assessments, the table below illustrates ...
NeuroPace, Inc., a medical device company dedicated to improving the lives of those with epilepsy, announced that its management will present at the Leerink Partners 2025 Global Healthcare Conference ...
Thank you, operator, and welcome to NeuroPace's fourth quarter and full year 2025 earnings conference call. Our agenda begins with Joel B ...
NeuroPace has hired the former chief financial officer of Staar Surgical, Patrick Williams, to replace its current financial chief. The medical-device company said Tuesday that Rebecca Kuhn has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results